It stands for Psychiatric Renewal Through Innovative Solutions and Methods. There are a couple of high profile treatments, ...

Treatment with the investigational psychedelic GH001 was linked with significant improvements in TRD that persist for at ...

BPL-003 is a novel, nasal spray formulation of mebufotenin benzoate designed to deliver rapid and durable antidepressant effects from a single dose.

Psilocybin could be the future of mental health care, with promising findings emerging from Australia's first research trial ...

Breakthrough Therapy designation recognizes the potential of BPL-003 to deliver substantial improvement over existing therapies for patients with ...

Moment of Clarity has released a new resource titled “Is Spravato Covered by Insurance?“, now available on their website. The ...

Nick Fournie was 24 years old when severe depression upended his life. Fournie had been married to his longtime sweetheart for two years, and had no reason to suspect he had any mental health issues. ...

A new study shows longer-term use of generic ketamine for severe depression is safe and effective, but researchers say access ...

Australia’s first psychedelic trial for treatment-resistant depression has uncovered potential markers that could predict ...

Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...

The Journal of Clinical Psychiatry recently published results from the RECOVER trial, a landmark study examining vagus nerve ...

Read A Biblical Path through Treatment-Resistant Depression by Dr. Audrey Davidheiser and more articles about PLUS on ...